Infliximab As a First Choice Therapy in Children with Newly Diagnosed Cronhn’s Disease ( CD ) Promotes Long-Term Sustained Remission and Alters the Course of the Disease / ) E., Romeo; F., Viola; DE ANGELIS, Gian Luigi; A., Vernuccio; V., Pannone; B., Bizzarri; O., Borrelli; S., Cucchiara. - In: GASTROENTEROLOGY. - ISSN 0892-1601. - 130:(2006).

Infliximab As a First Choice Therapy in Children with Newly Diagnosed Cronhn’s Disease ( CD ) Promotes Long-Term Sustained Remission and Alters the Course of the Disease

DE ANGELIS, Gian Luigi;
2006-01-01

2006
Infliximab As a First Choice Therapy in Children with Newly Diagnosed Cronhn’s Disease ( CD ) Promotes Long-Term Sustained Remission and Alters the Course of the Disease / ) E., Romeo; F., Viola; DE ANGELIS, Gian Luigi; A., Vernuccio; V., Pannone; B., Bizzarri; O., Borrelli; S., Cucchiara. - In: GASTROENTEROLOGY. - ISSN 0892-1601. - 130:(2006).
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11381/2432524
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact